Sodium; 5-ethoxycarbonyl-4-methyl-pyrimidin-2-olate, 95.0%, 1g

L-Alanine, N-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, 95%, 25g

2-(4-Boronophenyl)-2-methylpropanenitrile, 97.0%, 1g

Di-p-tolylphosphine oxide, 95.0%, 25g

1-(4-Chloro-2,6-difluorophenyl)piperidin-4-one, 98%, 250mg

3-(4-Bromo-3-methylphenyl)-5-methyl-1,2,4-oxadiazole, 97%, 1g

2,4-Dichloro-3-(trifluoromethyl)pyridine, 97.0%, 5g

Volumetric flasks class A Trapezoidal shape, 2 ml, 7/16, 2 Piece(s)

7-Methoxyimidazo[1,2-a]pyridine-3-carboxylic acid, 97%, 100mg

4-cyclohexyl-2-pyrrolidinone, 95.0%, 5g

4-{[1-(tert-Butoxycarbonyl)azetidin-3-yl]oxy}benzoic acid, 95.0%, 5g

Methyl 3-iodo-4-(trifluoromethoxy)benzoate, 97%, 1g

2-(2-Biphenylyl)amino-9,9-dimethylfluorene>98.0%(HPLC)1g